BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26656941)

  • 1. Uremic Solutes Produced by Colon Microbes.
    Tanaka H; Sirich TL; Meyer TW
    Blood Purif; 2015; 40(4):306-11. PubMed ID: 26656941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uremic solutes from colon microbes.
    Meyer TW; Hostetter TH
    Kidney Int; 2012 May; 81(10):949-954. PubMed ID: 22318422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colonic contribution to uremic solutes.
    Aronov PA; Luo FJ; Plummer NS; Quan Z; Holmes S; Hostetter TH; Meyer TW
    J Am Soc Nephrol; 2011 Sep; 22(9):1769-76. PubMed ID: 21784895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Enlarged Profile of Uremic Solutes.
    Tanaka H; Sirich TL; Plummer NS; Weaver DS; Meyer TW
    PLoS One; 2015; 10(8):e0135657. PubMed ID: 26317986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of Colon-Derived Uremic Solutes.
    Mair RD; Sirich TL; Plummer NS; Meyer TW
    Clin J Am Soc Nephrol; 2018 Sep; 13(9):1398-1404. PubMed ID: 30087103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of uremic solutes in the cerebrospinal fluid in experimental acute renal failure.
    Mair RD; Nguyen H; Huang TT; Plummer NS; Sirich TL; Meyer TW
    Am J Physiol Renal Physiol; 2019 Aug; 317(2):F296-F302. PubMed ID: 31141401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach.
    Mishima E; Fukuda S; Mukawa C; Yuri A; Kanemitsu Y; Matsumoto Y; Akiyama Y; Fukuda NN; Tsukamoto H; Asaji K; Shima H; Kikuchi K; Suzuki C; Suzuki T; Tomioka Y; Soga T; Ito S; Abe T
    Kidney Int; 2017 Sep; 92(3):634-645. PubMed ID: 28396122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary protein and fiber in end stage renal disease.
    Sirich TL
    Semin Dial; 2015; 28(1):75-80. PubMed ID: 25319504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomic analysis of uremic pruritus in patients on hemodialysis.
    Bolanos CG; Pham NM; Mair RD; Meyer TW; Sirich TL
    PLoS One; 2021; 16(2):e0246765. PubMed ID: 33577623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive Hemodialysis Fails to Reduce Plasma Levels of Uremic Solutes.
    Sirich TL; Meyer TW
    Clin J Am Soc Nephrol; 2018 Mar; 13(3):361-362. PubMed ID: 29444901
    [No Abstract]   [Full Text] [Related]  

  • 11. The clearance of unidentified uremic solutes (with molecular weight under 5 kDa) plays an important role in hemodialyzer selection.
    Chen TS; Liou SY; Chang YL
    Int Urol Nephrol; 2010 Jun; 42(2):465-70. PubMed ID: 19590973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and clinical evidence for uremic toxicity.
    Bouré T; Vanholder R
    Artif Organs; 2004 Mar; 28(3):248-53. PubMed ID: 15046622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CE-MS-Based Identification of Uremic Solutes Specific to Hemodialysis Patients.
    Akiyama Y; Kikuchi K; Toyohara T; Mishima E; Suzuki C; Suzuki T; Nakayama M; Tomioka Y; Soga T; Abe T
    Toxins (Basel); 2021 Apr; 13(5):. PubMed ID: 33946481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A liquid chromatography - tandem mass spectrometry method to measure a selected panel of uremic retention solutes derived from endogenous and colonic microbial metabolism.
    de Loor H; Poesen R; De Leger W; Dehaen W; Augustijns P; Evenepoel P; Meijers B
    Anal Chim Acta; 2016 Sep; 936():149-56. PubMed ID: 27566350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Uremic toxins].
    Vanholder R
    Nephrologie; 2003; 24(7):373-6. PubMed ID: 14650749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The kidney and uremic toxin removal: glomerulus or tubule?
    Masereeuw R; Mutsaers HA; Toyohara T; Abe T; Jhawar S; Sweet DH; Lowenstein J
    Semin Nephrol; 2014 Mar; 34(2):191-208. PubMed ID: 24780473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Removal of uremic retention products by hemodialysis is coupled with indiscriminate loss of vital metabolites.
    Zhang ZH; Mao JR; Chen H; Su W; Zhang Y; Zhang L; Chen DQ; Zhao YY; Vaziri ND
    Clin Biochem; 2017 Dec; 50(18):1078-1086. PubMed ID: 28928007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approaches to uremia.
    Meyer TW; Hostetter TH
    J Am Soc Nephrol; 2014 Oct; 25(10):2151-8. PubMed ID: 24812163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obstacles to reducing plasma levels of uremic solutes by hemodialysis.
    Sirich TL
    Semin Dial; 2017 Sep; 30(5):403-408. PubMed ID: 28558415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.